These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34330719)

  • 21. Thrombolytic Therapy During
    Haque O; Raigani S; Rosales I; Carroll C; Coe TM; Baptista S; Yeh H; Uygun K; Delmonico FL; Markmann JF
    Front Surg; 2021; 8():644859. PubMed ID: 34222314
    [No Abstract]   [Full Text] [Related]  

  • 22. Ex Situ Machine Perfusion of Human Donor Livers via the Surgically Reopened Umbilical Vein: A Proof of Concept.
    van Leeuwen OB; Fujiyoshi M; Ubbink R; Werner MJM; Brüggenwirth IMA; Porte RJ; de Meijer VE
    Transplantation; 2019 Oct; 103(10):2130-2135. PubMed ID: 30801511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
    Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
    Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porcine Liver Normothermic Machine Perfusion: Methodological Framework and Potential Pitfalls.
    Gilbo N; Wylin T; Heedfeld V; Jochmans I; Pirenne J; Friend P; Monbaliu D
    Transplant Direct; 2022 Jan; 8(1):e1276. PubMed ID: 34912950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo normothermic machine perfusion is safe, simple, and reliable: results from a large animal model.
    Nassar A; Liu Q; Farias K; D'Amico G; Tom C; Grady P; Bennett A; Diago Uso T; Eghtesad B; Kelly D; Fung J; Abu-Elmagd K; Miller C; Quintini C
    Surg Innov; 2015 Feb; 22(1):61-9. PubMed ID: 24694840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
    Prueksaritanont T; Chu X; Evers R; Klopfer SO; Caro L; Kothare PA; Dempsey C; Rasmussen S; Houle R; Chan G; Cai X; Valesky R; Fraser IP; Stoch SA
    Br J Clin Pharmacol; 2014 Sep; 78(3):587-98. PubMed ID: 24617605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions.
    Hanke N; Gómez-Mantilla JD; Ishiguro N; Stopfer P; Nock V
    Pharm Res; 2021 Oct; 38(10):1645-1661. PubMed ID: 34664206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics.
    Ishida K; Ullah M; Tóth B; Juhasz V; Unadkat JD
    Drug Metab Dispos; 2018 Jan; 46(1):66-74. PubMed ID: 29084782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary Bicarbonate, pH, and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers.
    Matton APM; de Vries Y; Burlage LC; van Rijn R; Fujiyoshi M; de Meijer VE; de Boer MT; de Kleine RHJ; Verkade HJ; Gouw ASH; Lisman T; Porte RJ
    Transplantation; 2019 Jul; 103(7):1405-1413. PubMed ID: 30395120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Drug-Drug Interaction Potential Between Sacubitril/Valsartan (LCZ696) and Statins Using a Physiologically Based Pharmacokinetic Model.
    Lin W; Ji T; Einolf H; Ayalasomayajula S; Lin TH; Hanna I; Heimbach T; Breen C; Jarugula V; He H
    J Pharm Sci; 2017 May; 106(5):1439-1451. PubMed ID: 28089685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.
    Shitara Y; Sugiyama Y
    Pharmacol Ther; 2006 Oct; 112(1):71-105. PubMed ID: 16714062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance.
    Fenner KS; Jones HM; Ullah M; Kempshall S; Dickins M; Lai Y; Morgan P; Barton HA
    Xenobiotica; 2012 Jan; 42(1):28-45. PubMed ID: 22077101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-life management of drug-drug interactions between antiretrovirals and statins.
    Courlet P; Livio F; Alves Saldanha S; Scherrer A; Battegay M; Cavassini M; Stoeckle M; Decosterd LA; Marzolini C;
    J Antimicrob Chemother; 2020 Jul; 75(7):1972-1980. PubMed ID: 32240298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Temperature on Porcine Liver Machine Perfusion From Donors After Cardiac Death.
    Nassar A; Liu Q; Farias K; Buccini L; Baldwin W; Bennett A; Mangino M; Irefin S; Cywinski J; Okamoto T; Diago Uso T; Iuppa G; Soliman B; Miller C; Quintini C
    Artif Organs; 2016 Oct; 40(10):999-1008. PubMed ID: 27086771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitavastatin as an in vivo probe for studying hepatic organic anion transporting polypeptide-mediated drug-drug interactions in cynomolgus monkeys.
    Takahashi T; Ohtsuka T; Yoshikawa T; Tatekawa I; Uno Y; Utoh M; Yamazaki H; Kume T
    Drug Metab Dispos; 2013 Oct; 41(10):1875-82. PubMed ID: 23929936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Assessment of Transporter Mediated Perpetrator DDIs for Several Hepatitis C Virus Direct-Acting Antiviral Drugs and Prediction of DDIs with Statins Using Static Models.
    Chu X; Chan GH; Houle R; Lin M; Yabut J; Fandozzi C
    AAPS J; 2022 Mar; 24(3):45. PubMed ID: 35314909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of [
    Yagi Y; Kimura H; Okuda H; Ono M; Nakamoto Y; Togashi K; Saji H
    Nucl Med Biol; 2019; 74-75():25-31. PubMed ID: 31450072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation and design of customized ex vivo machine perfusion. Analysis of its first results.
    Riveros S; Marino C; Ochoa G; Morales E; Soto D; Alegría L; Zenteno MJ; Brañes A; Achurra P; Rebolledo RA
    Artif Organs; 2022 Feb; 46(2):210-218. PubMed ID: 34519358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When Does the Rate-Determining Step in the Hepatic Clearance of a Drug Switch from Sinusoidal Uptake to All Hepatobiliary Clearances? Implications for Predicting Drug-Drug Interactions.
    Patilea-Vrana GI; Unadkat JD
    Drug Metab Dispos; 2018 Nov; 46(11):1487-1496. PubMed ID: 30115647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites.
    Zhang T
    Eur J Pharm Sci; 2015 Sep; 77():216-29. PubMed ID: 26116278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.